In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
FULCRUM PHARMA PLC Signs Second Preferred Supplier Arrangement A three year agreement with BTG
BTG to commercialise Coxsackievirus Vectors
CV signs ranolazine commercialisation agreement with Innovex
BTG Appoints Fulcrum Pharma as its Preferred Provider of Drug Development Services
BTG licenses analgesic compounds from Asterand
Performance Plants Inc. and BTG sign biotech agreement
Licence agreement between ReGen and Metagenics
BTG licenses Alzheimer's compounds To Senexis and co-invests £1 million with The Wellcome Trust